Abstract

Association studies provide genome-wide information about the genetic basis of complex disease, but medical research has primarily focused on protein-coding variants, due to the difficulty of interpreting non-coding mutations. This picture has changed with advances in the systematic annotation of functional non-coding elements. Evolutionary conservation, functional genomics, chromatin state, sequence motifs, and molecular quantitative trait loci all provide complementary information about non-coding function. These functional maps can help prioritize variants on risk haplotypes, filter mutations encountered in the clinic, and perform systems-level analyses to reveal processes underlying disease associations. Advances in predictive modeling can enable dataset integration to reveal pathways shared across loci and alleles, and richer regulatory models can guide the search for epistatic interactions. Lastly, new massively parallel reporter experiments can systematically validate regulatory predictions. Ultimately, advances in regulatory and systems genomics can help unleash the value of whole-genome sequencing for personalized genomic risk assessment, diagnosis, and treatment.

Keywords

BiologyComputational biologyGenomicsFunctional genomicsGeneticsEpistasisGenetic architectureGenomeQuantitative trait locusGene

Affiliated Institutions

Related Publications

Publication Info

Year
2012
Type
review
Citations
511
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

511
OpenAlex

Cite This

Lucas D. Ward, Manolis Kellis (2012). Interpreting non-coding variation in complex disease genetics. DSpace@MIT (Massachusetts Institute of Technology) . https://doi.org/10.1038/nbt.2422

Identifiers

DOI
10.1038/nbt.2422